Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study

References

• Peleg AY, Seifert, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.
   PubMed Web of Science ®Google Scholar
• Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumanii on dry surfaces. J Clin Microbiol. 1997;37:287–295.
   Google Scholar
• Hurly JC. World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression. BMC Infect Dis. 2016;16:577.
   PubMed Web of Science ®Google Scholar
• Lob SH, Hoban DJ, Sahm DF, Badal RE. Regional differences and trends in antimicrobial suscebility of Acinetobacter baumanii. Int J Antimicrob Agents. 2016;14:317–323.
   Google Scholar
• Garnacho- Montero J, Gutierrez-Pizarraya A, Diaz-Martin A, et al. Acinetobacter baumanii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality. Enferm Infecc Microbiol Clin. 2016;34(9):551–558.
   PubMed Web of Science ®Google Scholar
• Villar M, Cano ME, Gato E, et al; GEIH/GEMARA/REIPI-Ab20101 Group. Epidemiologic and clinic impact of Acinetobacter baumanii colonization and infection: a reappraisal. Medicine (Baltimore). 2014;93:202–210.
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Nathanson BH, Sultham K, Fan W, Shorr AF. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumanii pneumonia and sepsis. Crit Care. 2016;20:221.
   PubMed Web of Science ®Google Scholar
• Chopra T, Marchaim D, Awali RA, et al. Epidemiology of bloodstream infections caused by Acinetobacter baumanii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother. 2013;57(12):6270–6275.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Blizotis IA, Siempos II. Attributable mortality of Acinetobacter baumanii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006;10:R48.
   PubMed Web of Science ®Google Scholar
• Rebmann T, Rosenbaum PA. Preventing the transmission of multidrug-resistant Acinetobacter baumanii: an executive summary of Association for Professionals in Infection Control and Epidemiology’s Elimination Guide. Am J Infect Control. 2011;39:439–441.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Cataldo MA, Dancer SJ, et al; European Society of Clinical Microbiology. European Society of Clinical microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in acute care setting. Am J Infect Control. 2008;36:309–332.
   PubMed Web of Science ®Google Scholar
• CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and criteria for specific types of Infections in Acute care Setting. A summary of Key HAIs. Available from: http://www.socinorte.com/wp-content/uploads/2013/03/Griterios-de-IN-2013.pdf.
   Google Scholar
• EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. 2016. Available from: http://www.eucast.org/clinical_breakpoints/. Accessed January, 2016.
   Google Scholar
• Duszyńska W, Barteczko-Grajek B, Kübler A. Monitoring of nosocomial infections using the HELICS network. Anaesthesiol Intensive Ther. 2008;40:17–21.
   Google Scholar
• Rutkowska K, Przybyła M, Misiołek H. Health-care associated infection in the newly opened intensive care unit. Anaesthesiol Intensive Ther. 2013;45(2):64–68.
   Google Scholar
• Wieder-Huszla S. Monitorowanie zakazen szpitalnych na oddziałach intensywnej terapii [Monitoring of nosocomial infections in intensive care units]. Ann Acad Med Stetin. 2010;56(3):20–29. Polish
   PubMedGoogle Scholar
• Vincent J-L, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274(8):639–644.
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Rello J, Marshall J, et al; EPIC II Group of Investigators. International study of prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329.
   PubMed Web of Science ®Google Scholar
• Agodi A, Zarrili R, Barchitta M, et al. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clin Microbiol Infect. 2006;12:241–247.
   PubMed Web of Science ®Google Scholar
• Apisaarnthanarak A, Pinitchai U, Warachan B, Warren DK, Khawcharoenporn T, Hayden MK. Effectiveness of infection prevention measurements featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in Thai intensive care unit: an analysis before and after extensive flooding. Am J Infect Control. 2014;42(2):116–121.
   PubMed Web of Science ®Google Scholar
• Ardoino I, Zangirolami F, Iemmi D, et al. Risk factors and epidemiology of Acinetobacter baumanii infections in a university hospital in Northern Italy: a case-control study. Am J Infect Control. 2016;44:1600–1605.
   PubMed Web of Science ®Google Scholar
• Moreira MR, Filho PG. Multidrug–resistant pathogens causing ventilator-associated pneumonia: risk factors, empirical antimicrobial therapy and outcome of patients in an intensive care unit (ICU) of Brazilian university hospital. Int J Med Sci. 2012;4(9):204–210.
   Google Scholar
• Dima S, Kritsotakis EI, Roumbelaki M, et al. Device-associated nosocomial infection rates in intensive care units in Greece. Infect Control Hosp Epidemiol. 2007;28:602–605.
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance interactive database (EARS–Net) Available from: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx. Accessed September 4, 2014.
   Google Scholar
• Maraki S, Mantadakis E, Mavramanolaki VE, Kofteridis DP, Samonis G. A 5-year surveillance study on antimicrobial resistance of Acinetobacter baumanii clinical isolates from a tertiary Greek Hospital. Infect Chemother. 2016;48(3):190–198.
   PubMedGoogle Scholar
• Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301.
   PubMed Web of Science ®Google Scholar
• Hackel MA, Badal RE, Bouchillon SK, Biedenbach DJ, Hoban DJ. Resistance rates of intra-abdominal isolates from intensive care units and non-intensive-care units in the United States: the study monitoring antimicrobial resistance trends 2010–2012. Surg Infect (Larchmt). 2015;16(3):298–304.
   PubMed Web of Science ®Google Scholar
• Rosenthal VD, AL-Abdely-H M, EL-Kholy AA, et al. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010–2015. Device-associated module. Am J Infect Control. 2016;44(12):1495–1504.
   PubMed Web of Science ®Google Scholar